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A b s t r a c t  
Curcumin, a natural compound isolated from rhizomes of the herb Curcuma longa, is suggested as 
a potential therapeutic agent thanks to its multiple biological and pharmaceutical activities including 
anti-inflammatory, anti-oxidant, wound healing, anti-microbial and anti-cancer activities. Particularly, 
Curcumin has demonstrated efficacy as an anticancer agent for various kinds of cancer. However, 
its low aqueous solubility and bioavailability hamper its clinical application. Therefore, many drug 
delivery systems have been developed to overcome these limitations.  In this study, by using 
polymeric micelles composed by poly (lactide)-poly (ethylenglycol) (PLA-PEG) copolymers, the 
aqueous solubility of Curcumin was increased to 0.73 mg.mL-1 compared to 0.11ï10-4 mg.mL-1 of 
pure Curcumin. In addition, we found that the ratio of PLA/PEG has large impact on Curcumin 
solubility, Curcumin encapsulation efficiency, size and Curcumin release behavior of polymeric 
micelles. The increase in Curcumin solubility, Curcumin encapsulation efficacy and particle size but 
decrease in Curcumin release rate were observed when increasing the PLA/PEG ratio. 
Keywords: Chemotherapy, Curcumin, Poly(lactide)-polyethylene glycol (PLA-PEG),copolymer, 
polymeric micelle. 
Introduction 
Chemotherapy is the most common method applied in cancer 
treatment. It can be used alone or in combination with other cancer 
treatment methods in order to improve the therapeutic efficacy. 
However, drugs used in chemotherapy still remain many problems 
relating to severe adverse effects for patients. The reason is that 
anti-cancer drugs can not be able to recognize the difference 
between cancer cell and normal cell leading to destroying both of 
them. Therefore, developing new drugs or drug formulations that 
are safe for patients but still induce high anti-cancer activity is very 
necessary.  
Curcumin, a natural compound isolated from rhizomes of the herb 
Curcuma longa, has received considerable attentions because of 
its multiple biological and pharmaceutical activities including anti-
inflammatory, anti- oxidant, wound healing, anti-microbial and anti-
cancer activities [1]. The anti-cancer activity has been extensively 
studied. It was suggested Curcumin as a potential agent for both 
prevention and treatment of various cancers such as 
gastrointestinal, melanoma, genito-urinary, breast, lung, 
hematological, head and neck, neurological and sarcoma [2-4]. 
Interestingly, Curcumin has been demonstrated having no toxic 
effects on  normal cells at the concentration as high as 50 øM while 
still exhibiting good anti-cancer activity [5]. Recent clinical study 
also indicated that oral administration of Curcumin was well 
tolerated at doses of 12g/day [6]. 
Despite of the potential biological and pharmaceutical properties of 
Curcumin, its clinical applications are still limited because of its 
poor water solubility and low bioavailability. It was reported that the 
solubility of Curcumin in aqueous buffer is only 0.11ï10-4 mg.mL-1 
[7] and its oral bioavailability is 1% [8].  In order to increase the 
water solubility and bioavailability of Curcumin, many drug delivery 
systems have been studied such as liposome, polymeric micelle, 
polymeric nanoparticle, conjugate, peptide/protein carrier [9]. 
Among them, polymeric micelles have attracted great deal of 
attention thanks to their small size,  highly structural stability, high 
drug loading capacity and good bioavailability [10, 11]. Polymeric 
micelles have a core-shell structure with the hydrophobic core 
serving as microenvironment for incorporating hydrophobic drugs 
and the hydrophilic shell stabilizing the micelles and protecting 
hydrophobic drugs from physiological environment of the body [12]. 
Core/shell ratio of polymeric micelle was demonstrated having 
large impact on hydrophobic drug loading capacity, stability, 
pharmaceutical and biological activities of polymeric systems [13, 
14].  
In this study, we aimed to study the impact of PLA/PEG ratios on 
Curcumin solubility, Curcumin encapsulation efficacy, size and also 
the Curcumin release behavior of Curcumin loaded polymeric 
micelles composed by PLA-PEG copolymers. 
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Materials and Methods  
Materials  
Curcumin (Cur), lactic acide (LA), polyethylen glycol (PEG 2000), 
stannuos octoate (Sn(Oct)2) were purchased from Sigma (USA). 
Solvents (toluen, dichlomethan, methanol, ethanol, phosphate 
buffered saline PBS (pH 7.4)) were purchased from Merck 
(Germany). All chemicals were used without further purification. 
Distilled water was used for all experiments. 
Synthesis of copolymers  
PLA-PEG copolymers were synthesized by ring-opening 
polymerzation of lactic monomer (LA) and PEG using stannuous 
octoate as catalyst [15]. The ratios of LA/PEG (w/w) were changed 
in the range of 3:1; 2:1; 1:1; 1:2; 1:3. Polymerization reaction was 
performed at 1450C under magnetical stirring. After 10h reaction, 
solvent was evaporated at 1100C. Obtained copolymer was 
dissolved in DCM and then purified by precipitating in cool 
methanol. Purification process was repeated three times and the 
copolymer was dried under vacuum at 450C for 48 h. 
Preparation of PLA-PEG polymeric micelles (PLA-PEG 
NPs) 
PLA-PEG NPs were prepared by dissolving 60 mg copolymer in 40 
ml distilled water and magnetically stirring for 6h. After that, the 
mixture was centrifuged at 5000 rpm for 10 minute to remove 
undispersed copolymer. The obtained solution was lyophilized to 
collect dry PLA-PEG NPs and then stored at 40C for further uses.  
Preparation of Curcumin loaded PLA-PEG polymeric 
micelles (Cur/PLA-PEG NPs) 
Five kinds of copolymer with the different ratios of PLA/PEG (3:1; 
2:1; 1:1; 1:2; 1:3 (w/w)) were used to prepare Cur/PLA-PEG NPs 
by emulsification/solvent evaporation method. In brief, 150 mg 
copolymer was dispersed in 100 ml distilled water (solution A) and 
magnetically stirring for 6h to ensure complete homogeneity. 80 mg 
Curcumin was dissolved in 100 ml ethanol (solution B). The 
solution B was added dropwise to the solution A under 
magnetically stirring at room temperature. After 48 h stirring, the 
solvent (ethanol) was evaporated and the obtained mixture was 
centrifuged at 5000 rpm for 10 minutes in order to remove 
unencapsulated Curcumin. A half of obtained transparent solution 
was lyophilized to obtain dry Cur/PLA-PEG NPs. Solution and dry 
samples were stored at 40C for further use. 
Curcumin encapsulation efficiency 
Curcumin encapsulation efficiency (EE) was calculated by following 
formula: 
EE ሺ%ሻ
ൌ  
Total amount of Cur െ unencapsulated amount of Cur
Total amount of Cur
 
ൈ 100 
Curcumin release behavior 
5 mg dry Cur/PLA-PEG NPs was redispersed in 20 ml phosphate 
buffered saline (PBS, pH 7.4). The dispersion was incubated in 
water bath at 370C. After each period of time, 3 ml sample was 
taken and 3 ml distilled water was added. The taken sample was 
centrifuged at 5000 rpm for 10 minutes to remove released 
Curcumin. Concentration of Curcumin in obtained solution was 
measured by Ultraviolet-Visible spectroscopy. Curcumin release 
was calculated based on the following formula: 
 
Cur release ሺ%ሻ ൌ  
׋଴െ׋௧
׋଴
ൈ 100 
Where, C0: initial concentration of Curcumin 
 Ct: Concentration of Curcumin at time t 
Characterization methods 
Surface morphology and particle size of nanoparticles were 
investigated by by Field Emission Scanning Electron Microscopy 
(FE-SEM, Hitachi S-4800). Curcumin concentration was 
determined by Ultraviolet-Visible Spectrometer (UV-Vis Aligent 
8453).  
Results and Discussion 
Morphology and size of PLA-PEG NPs and Cur/PLA-
PEG NPs 
FE-SEM method was used to investigate morphology and size of 
PLA-PEG NPs and Cur/PLA-PEG NPs (fig.1). The results showed 
that both PLA-PEG NPs and Cur/PLA-PEG NPs have spherical 
shape. There were changes in size of polymeric micelles 
composed by different PLA-PEG copolymer. Size of PLA-PEG NPs 
increased from 49 to 58 nm when ratio of PLA/PEG (w/w) 
increased from 1:3 to 3:1. Interestingly, size of PLA-PEG NPs 
almost had no changes when the ratio of PLA/PEG increased from 
1:3 to 1:1 and remarkably increased when this ratio increased from 
1:1 to 3:1 (Table 1). This result led us to assume that higher PLA 
component  induces the larger nanoparticle. This result is in good 
agreement with other results studying the role of hydrophobic 
segment of copolymers on size of polymeric micelles [13]. High 
PEG component, meanwhile, seems not to impact to the size of 
nanoparticle. However, PEG component was demonstrated playing 
very important role for improving blood circulation time and 
avoiding recognition of reticuloendothelial system of drug delivery 
systems [16]. Similar to PLA-PEG NPs, size of nanoparticles 
containing drug Cur/PLA-PEG NPs also increased from 60 nm to 
69 nm when the ratio of PLA/PEG increased from 1:3 to 3:1 (w/w) 
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Table 1. Characteristics of Cur/PLA-PEG NPs 
Ratios of 
PLA/PEG 
(w/w) 
Size of nanoparticles (nm) Cur Solubility 
(mg.mL-1) 
EE (%) 
PLA-PEG NPs Cur/PLA-PEG NPs 
1:3 
1:2 
1:1 
2:1 
3:1 
49.5 μ 1.6 
49.7 μ 1.6 
50.2 μ 1.6 
55.2 μ 1.7 
58.2 μ 1.8 
60.6 μ 1.4 
60.7 μ 1.4 
60.5 μ 1.5 
65.7 μ 1.7 
69.2 μ 1.9 
0.39 
0.40 
0.43 
0.63 
0.73 
48.8 
50 
53.8 
78.8 
91.3 
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Figure.2. Impact of PLA/PEG ratios on particle size of PLA-
PEG NPs and Cur/PLA-PEG NPs 
Figure.3. Changes of particle mean size  and Curcumin 
encapsulation efficiency of Cur/PLA-TPGS when increasing 
PLA/PEG ratio 
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Figure.4 Calibration curve of Curcumin dissolved in ethanol Figure. 5. UV spectra of Cur/PLA-PEG NPs dissolved in ethanol
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Curcumin solubility was measured by UV spectrometer. 0.1 ml of 
each solution sample was added to 9.9 ml ethanol and then 
measured in the wavelength range of 300-800 nm. The Curcumin 
solubility was calculated from the absorbance of Curcumin at 431 
nm based on the equation obtained from the calibration curve of 
Curcumin in ethanol (fig.4). This wavelength is not interfered by the 
presence of copolymers. The Curcumin solubility in aqueous 
solution was greatly increased with the increased component of 
PLA, achieving highest value (0.73 mg.mL-1) at the ratio of 
PLA/PEG being 3:1. Meanwhile, there was no obvious increase of 
Curcumin solubility when the ratio of PLA/PEG varied from 1:3 to 
1:1 (around 0.4 mg.ml-1). For this result, we suggested that the 
PLA component significantly influences on the Curcumin solubility. 
Higher PLA component results to better Curcumin solubility. The 
increase in Curcumin solubility may be attributed to the increased 
hydrophobic interactions between drug and hydrophobic core of 
polymeric micelles [18]. 
Curucumin encapsulation efficiency also increased remarkably 
when increasing the PLA/PEG ratio. It was around 50% when 
PLA/PEG ratio was from 1:3 to 1:1 and increased strongly reaching 
91.3% when the PLA/PEG ratio was 3:1. 
Curcumin release behavior 
Fig. 6. shows the Curcumin release from Cur/PLA-PEG NPs. For 
all cases, the Curcumin release from nanoparticles displayed a 
biphasic release profile. The initial burst associated with the fast 
release of drug molecules located in the shell or at the core-shell 
interface of polymeric micelles took place in the first 12h. In the 
second phase, Curcumin was progressively released 
corresponding to the diffusion of Curcumin from the inner core into 
the outer aqueous environment. This release kinetic has been well-
documented for most polymeric micelles [19-21]. However, 
Curcumin release rate was different for each kind of Cur/PLA-PEG 
NPs. It was fastest when curcumin was encapsulated in polymeric 
micelles composed by PLA-PEG at the ratio of PLA/PEG being 1:3. 
It was slower at higher PLA/PEG ratios. These results could be 
explained by two reasons. Firstly, higher PLA component could 
lead to stronger hydrophobic interaction between Curcumin and the 
hydrophobic core [22]. Secondly, at lower loading, Curcumin 
maybe  present as a dispersed state in the core segment whereas 
a crystallization of drug in the PLA core occurs at higher loading 
[23]. The crystalized drug would be more slowly dissolved and 
diffused into the outer aqueous environment [24]. 
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Figure.6. Curcumin release profiles of Cur/PLA-PEG NPs
 
Conclusion 
Curcumin is a potential therapeutic agent owning a lot of 
bioactivities including anti-inflammatory, anti-oxidant, wound 
healing, anti-microbial and anti-cancer activities. However, its low 
aqueous solubility and bioavailability are major obstacles for its 
clinical applications. In this study, polymeric micelles composed by 
PLA-PEG copolymers were applied in order to improve Curcumin 
limitations. Systematic investigation showed that PLA/PEG ratio of 
PLA-PEG copolymer has large impact on Curcumin solubility, 
encapsulation efficiency, size and Curcumin release behavior of 
Cur/PLA-PEG NPs. Higher PLA/PEG ratio results in better 
Curcumin solubility, encapsulation efficiency and larger particle 
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size. Reversely, Curcumin release rate decreased when PLA/PEG 
increased. Noticeably, these changes were clearly happened when 
the PLA/PEG ratio increase from 1:1 to 3:1. However, as 
discussed, PEG component plays very important role determining 
efficiency of drug delivery system after administration. Therefore, 
optimum PLA/PEG ratio is only achieved by further intensive 
studies on cellular uptake and bioavailability of Cur/PLA-PEG NPs. 
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